Figure 3.The association between CLCN4 expression and cancer pathological grades (stage I, II, III, IV). (A) ACC. (B) KIRC. (C) LUAD. (D) PAAD. (E) TGCT. (F) THCA.
Figure 3 — Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer | Aging
